Literature DB >> 21635226

High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation.

S-Y Lu1, K-Y Liu, D-H Liu, L-P Xu, X-J Huang.   

Abstract

Regulatory T cells (T(regs) ) play a key role in the prevention of acute graft-versus-host disease (aGVHD). To investigate the association between T(reg) subsets and aGVHD, we prospectively analysed T cell subsets in the allografts of 35 patients undergoing myeloablative unmanipulated haematopoietic stem cell transplantation. Multivariate analysis found that patients infused with less than 0·29 × 10(6) /kg of CD4(+) CD25(high) CD45RA(+) CD62L(+) T cells during transplantation exhibited an increased incidence of II-IV aGVHD [hazard ratio (HR) = 0·000, 95% CI = 0·000-0·106, P = 0·013]. Next, we compared the reconstitution characteristics of T cell subsets between haploidentical haematopoietic stem cell transplantation (HSCT) and sibling HSCT by collecting peripheral blood samples at regular intervals (days 30, 60 and 90) after transplantation. No significant differences were observed in the reconstitution of conventional T cells between haploidentical HSCT and sibling identical HSCT. However, total counts of recovered naiveT(regs) and CD62L(+) naive T(regs) from haploidentical HSCT were significantly lower compared to sibling identical HSCT; P-values were 0·045 and 0·021, respectively. Although total counts of conventional T cells in aGVHD patients reached similar levels compared to non-aGVHD patients before day 60 post-HSCT, total counts of naive T(regs) and CD62L(+) naive T(regs) in aGVHD patients did not reach similar levels to non-aGVHD patients until 90 days post-HSCT. Taken together, our findings demonstrate that a large population of CD62L(+) naive T(regs) in allografts reduces the incidence of aGVHD. Further, development of aGVHD is related closely to the delayed reconstitution of the naive T(reg) population.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21635226      PMCID: PMC3142651          DOI: 10.1111/j.1365-2249.2011.04418.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  49 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

Review 2.  Regulatory T cells in transplantation tolerance.

Authors:  Kathryn J Wood; Shimon Sakaguchi
Journal:  Nat Rev Immunol       Date:  2003-03       Impact factor: 53.106

3.  Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells.

Authors:  Cristina Cozzo; Joseph Larkin; Andrew J Caton
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

4.  Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function.

Authors:  Angela M Thornton; Erin E Donovan; Ciriaco A Piccirillo; Ethan M Shevach
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

5.  L-selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation.

Authors:  M J Carlson; L M Fulton; J M Coghill; M L West; J E Burgents; Y Wan; A Panoskaltsis-Mortari; T F Tedder; B R Blazar; J S Serody
Journal:  Am J Transplant       Date:  2010-11-10       Impact factor: 8.086

6.  CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation.

Authors:  J M Zaucha; T Gooley; W I Bensinger; S Heimfeld; T R Chauncey; R Zaucha; P J Martin; M E Flowers; J Storek; G Georges; R Storb; B Torok-Storb
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

7.  The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

Authors:  Patricia A Taylor; Christopher J Lees; Bruce R Blazar
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

8.  Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings.

Authors:  Alvaro Urbano-Ispizua; Ciril Rozman; Pedro Pimentel; Carlos Solano; Javier de la Rubia; Salut Brunet; Jaime Pérez-Oteyza; Christelle Ferrá; Javier Zuazu; Dolores Caballero; Joan Bargay; Alzira Carvalhais; Jose Luis Díez; Ildefonso Espigado; Adrián Alegre; Montserrat Rovira; Fernando Campilho; Jesús Odriozola; Miguel Angel Sanz; Jordi Sierra; Javier García-Conde; Emili Montserrat
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

9.  [Treatment of severe steroid-refractory graft-versus-host disease with IL-2R alpha chain (CD25) monoclonal antibody].

Authors:  Jin Lu; Lan-ping Xu; Xiao-jun Huang; Huan Chen; Yao-chen Zhang; Han-yun Ren; Nai-lan Guo; Dao-pei Lu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2003-02-10

10.  Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

Authors:  M K Levings; R Sangregorio; M G Roncarolo
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

View more
  11 in total

1.  Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update.

Authors:  W Arcese; A Picardi; S Santarone; G De Angelis; R Cerretti; L Cudillo; E Pennese; P Bavaro; P Olioso; T Dentamaro; L Cupelli; A Chierichini; A Ferrari; A Mengarelli; M C Tirindelli; M Testi; F Di Piazza; P Di Bartolomeo
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

Review 2.  Therapeutic use of regulatory T cells for graft-versus-host disease.

Authors:  Shlomo Elias; Alexander Y Rudensky
Journal:  Br J Haematol       Date:  2019-08-16       Impact factor: 6.998

3.  Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.

Authors:  Lauren V Schnabel; Christian M Abratte; John C Schimenti; M Julia Bevilaqua Felippe; Jennifer M Cassano; Teresa L Southard; Jessica A Cross; Lisa A Fortier
Journal:  Regen Med       Date:  2014-04-28       Impact factor: 3.806

4.  The role of regulatory T cells in the biology of graft versus host disease.

Authors:  Amy J Beres; William R Drobyski
Journal:  Front Immunol       Date:  2013-06-24       Impact factor: 7.561

5.  Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation.

Authors:  Cristina Skert; Simone Perucca; Marco Chiarini; Viviana Giustini; Alessandra Sottini; Claudia Ghidini; Stefano Martellos; Federica Cattina; Benedetta Rambaldi; Valeria Cancelli; Michele Malagola; Alessandro Turra; Nicola Polverelli; Simona Bernardi; Luisa Imberti; Domenico Russo
Journal:  PLoS One       Date:  2017-04-11       Impact factor: 3.240

6.  Comprehensive phenotyping of regulatory T cells after liver transplantation.

Authors:  Anna Gronert Álvarez; Paraskevi Fytili; Pothakamuri V Suneetha; Anke R M Kraft; Christin Brauner; Jerome Schlue; Till Krech; Frank Lehner; Christoph Meyer-Heithuis; Elmar Jaeckel; Juergen Klempnauer; Michael P Manns; Markus Cornberg; Heiner Wedemeyer
Journal:  Liver Transpl       Date:  2015-01-20       Impact factor: 5.799

Review 7.  Review of Haploidentical Hematopoietic Cell Transplantation.

Authors:  Mehreen A Khan; Qaiser Bashir; Qamar-Un-Nisa Chaudhry; Parvez Ahmed; Tariq M Satti; Syed K Mahmood
Journal:  J Glob Oncol       Date:  2018-12

8.  Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability.

Authors:  Jeong-Su Do; Daniel Zwick; Jonathan D Kenyon; Fei Zhong; David Askew; Alex Y Huang; Wouter Van't Hof; Marcie Finney; Mary J Laughlin
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.379

9.  FK506 and Lactobacillus acidophilus ameliorate acute graft-versus-host disease by modulating the T helper 17/regulatory T-cell balance.

Authors:  Jin-Ah Beak; Min-Jung Park; Se-Young Kim; JooYeon Jhun; Jin Seok Woo; Jeong Won Choi; Hyun Sik Na; Soon Kyu Lee; Jong Young Choi; Mi-La Cho
Journal:  J Transl Med       Date:  2022-02-25       Impact factor: 5.531

10.  Third-party regulatory T cells prevent murine acute graft-versus-host disease.

Authors:  Jung-Yeon Lim; Keon-Il Im; Yunejin Song; Nayoun Kim; Young-Sun Nam; Young-Woo Jeon; Seok-Goo Cho
Journal:  Korean J Intern Med       Date:  2017-10-19       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.